Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02481206 · ClinicalTrials.gov registry record · NA
Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study
A NA study, sponsored by Zoll Medical Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT02481206 is a NA study that was terminated before completion, run by Zoll Medical Corporation. The registered enrollment target is 66 participants.
The verdict
NCT02481206, a NA study, was terminated before completion, sponsored by Zoll Medical Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
A multi-center, prospective, randomized controlled clinical trial with 1:1 assignment of treatment and control. This study will evaluate the impact of wearable cardioverter defibrillator use on sudden cardiac death in incident hemodialysis patients. The study will enroll up to 2,600 subjects. A maximum of 200 sites in the USA will be used for enrollment.
Interventions
- DEVICE Wearable Cardioverter Defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02481206
The ClinicalTrials.gov registry entry for NCT02481206 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wearable Cardioverter Defibrillator is the first listed.
NCT02481206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02481206 about?
NCT02481206 is a clinical study titled "Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study". A multi-center, prospective, randomized controlled clinical trial with 1:1 assignment of treatment and control. This study will evaluate the impact of wearable cardioverter defibrillator use on sudden cardiac death in incident hemodialysis patients. The study will enroll up to 2,600 subjects. A maxi...
What is the current status of trial NCT02481206?
This trial is currently terminated. It is a NA study. The enrollment target is 66 participants. The study started on 2015-06. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02481206?
The interventions under investigation include: Wearable Cardioverter Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT02481206?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.